Publications by authors named "Shijie Mai"

Claim this Profile
F
Fungal microbiota signatures anticipate neoadjuvant immunochemotherapy outcomes in esophageal cancer.
Liping Liang, Shijie Mai, Gautam Sethi, Yingjie Luo, Zeheng Ma

J Immunother Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma.
Le Liu, Liping Liang, YingJie Luo, Jimin Han, Di Lu, Shijie Mai

Research (Wash D C)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
From microbes to medicine: harnessing the power of the microbiome in esophageal cancer.
Xiaoyan Liu, Bang Li, Liping Liang, Jimin Han, Shijie Mai

Front Immunol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel machine learning model based on ubiquitin-related gene pairs and clinical features to predict prognosis and treatment effect in colon adenocarcinoma.
Liping Liang, Le Liu, Shijie Mai, Ye Chen

Eur J Med Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: an initially unresectable stage III pulmonary sarcomatoid carcinoma qith EGFR mutation achieving pathological complete response following neoadjuvant therapy with osimertinib plus chemotherapy.
Xiguang Liu, Yating Zheng, Shijie Mai, Yu Tong, Lili Yang

Front Oncol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA damage repair-related gene signature predicts prognosis and indicates immune cell infiltration landscape in skin cutaneous melanoma.
Liping Liang, Shijie Mai, Genghui Mai, Ye Chen, Le Liu

Front Endocrinol (Lausanne)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' response: Comment on "clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma".
Di Lu, Jianjun Yang, Xiguang Liu, Siyang Feng, Xiaoying Dong, Shijie Mai

Cancer Med· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and Validation of Lactate Metabolism-Related lncRNA Signature as a Prognostic Model for Lung Adenocarcinoma.
Shijie Mai, Liping Liang, Genghui Mai, Xiguang Liu, Dingwei Diao

Front Endocrinol (Lausanne)· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA miR205HG hinders HNRNPA0 translation: anti-oncogenic effects in esophageal carcinoma.
Xiaoying Dong, Xuyuan Chen, Di Lu, Dingwei Diao, Xiguang Liu, Shijie Mai

Mol Oncol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oesophageal squamous cell carcinoma-associated IL-33 rewires macrophage polarization towards M2 via activating ornithine decarboxylase.
Shijie Mai, Le Liu, Jianjun Jiang, Pengfei Ren, Dingwei Diao

Cell Prolif· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circular RNA circNELL2 Acts as the Sponge of miR-127-5p to Promote Esophageal Squamous Cell Carcinoma Progression.
Gang Xiong, Dingwei Diao, Di Lu, Xiguang Liu, Zhaoguo Liu, Shijie Mai

Onco Targets Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathological features, survival outcomes, and appropriate surgical approaches for stage I acinar and papillary predominant lung adenocarcinoma.
Di Lu, Jianjun Yang, Xiguang Liu, Siyang Feng, Xiaoying Dong, Shijie Mai

Cancer Med· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages.
Di Lu, Zhen Ni, Xiguang Liu, Siyang Feng, Xiaoying Dong, Shijie Mai

J Immunol Res· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case report: Crizotinib is effective in a patient with ROS1-rearranged pulmonary inflammatory myofibroblastic tumor.
Shijie Mai, Gang Xiong, Dingwei Diao, Wenjing Wang, Yujie Zhou

Lung Cancer· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis